Sanofi Begins Construction of Frankfurt Insulin Ingredient Plant
The facility is planned for full production in 2032, once licensed, and is expected to expand Sanofi’s European insulin manufacturing capacity.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.